New York State Common Retirement Fund
RPTX

New York State Common Retirement Fund’s Repare Therapeutics RPTX Stock Holding History

New York State Common Retirement Fund’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,323
Closed -$4.55K – 3187
2024
Q3 		$4.55K Hold
1,323
– – ﹤0.01% 3144
2024
Q2 		$4.37K Hold
1,323
– – ﹤0.01% 3250
2024
Q1 		$6.23K Hold
1,323
– – ﹤0.01% 3208
2023
Q4 		$9.66K Hold
1,323
– – ﹤0.01% 3196
2023
Q3 		$16K Hold
1,323
– – ﹤0.01% 3195
2023
Q2 		$14K Buy
+1,323
New +$13.6K ﹤0.01% 3253

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

New York State Common Retirement Fund's RPTX Position: Q4 2024 in Review

New York State Common Retirement Fund sold out of Repare Therapeutics (RPTX) in Q4 2024, closing a stake of 1,323 shares — an estimated $4.55K sold.

New York State Common Retirement Fund first reported a position in RPTX in Q2 2023 and held it in 6 quarters. The position peaked at $16K in Q3 2023. 54 funds tracked by Wall St. Rank hold RPTX as of Q4 2024.

  • New York State Common Retirement Fund reported no remaining Repare Therapeutics position as of Q4 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,323 Repare Therapeutics shares in Q4 2024, an estimated $4.55K.
  • New York State Common Retirement Fund first reported a position in Repare Therapeutics in Q2 2023 and held it in 6 quarters.
  • New York State Common Retirement Fund's Repare Therapeutics position peaked at $16K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2024.

Based on New York State Common Retirement Fund's 13F filing for Q4 2024, filed 31 Jan 2025.